Scott-Macon Group (SMG Securities) Research
Advisory Approach
Scott-Macon Group, now operating as SMG Securities, Inc., embodies a distinctly client-centric philosophy in middle-market M&A advisory. Founded in 1973 by Alfred L. Scott, the firm has maintained for over 50 years a commitment to thoughtful, relationship-driven advisory rather than transaction-driven models. Their thesis is straightforward but powerful: superior outcomes for sellers emerge from senior-level expertise, deep operating experience, and unwavering commitment to client objectives—not from aggressive deal velocity.
What differentiates Scott-Macon is not flashy marketing but consistent institutional practice. They deliberately staff engagements with Managing Directors and senior professionals, each averaging 20+ years of M&A experience. Many team members bring direct operating backgrounds, having served as CFOs, plant managers, or business unit leaders before joining banking. This operating perspective permeates client advice, allowing them to counsel clients on value creation, operational risks, and realistic buyer expectations—not just transaction mechanics.
Sector Focus & Track Record
Scott-Macon has built deep expertise across five core verticals: healthcare services, industrial manufacturing, business services, consumer products & retail, and transportation & logistics. Within healthcare, they have completed over 200 mergers, acquisitions, and financing transactions with aggregate values exceeding $5 billion. Their healthcare group, led by Managing Director Nathan D. Cortright, serves companies across services, products, providers, information technology, medical devices, and pharmaceuticals.
The industrial group specializes in manufacturing businesses, chemical companies, and equipment-related transactions. Recent transactions include advising on manufacturing acquisitions, specialty chemical sales, and industrial services deals. Their consumer and retail group, headed by Managing Director Scott Silverman, brings expertise in consumer products, food & beverage, and retail businesses. The chemicals practice, led by Vice Chairman Allan Benton, maintains active relationships with specialty chemical producers and strategic acquirers.
Deal Track Record
Scott-Macon's deal history spans decades and multiple market cycles. Representative recent and historical transactions include: National Bill Audit Services (NBAS) acquisition by Exponent Health (healthcare services, May 2022); SureFit LLC acquisition by Hanger Prosthetics (medical equipment, 2010); Interactive Clinical Intelligence acquisition by Providence Equity (biotech research); Arizona Chemical acquisition by Rhone Capital (specialty chemicals); Jones & Bartlett Publishers acquisition by Providence Equity (publishing); Indiana Health Network acquisition by Great-West Life & Annuity (health insurance); CareScout acquisition by Genworth Financial (healthcare). These deals demonstrate breadth across industries, buyer types (strategic, PE, financial sponsor), and transaction complexity.
Process & Fee Structure
Scott-Macon's engagement process reflects their institutional, relationship-focused approach. They typically work exclusively with sellers and conduct comprehensive buyer outreach programs. The firm offers custom-tailored engagement structures based on client needs, ranging from traditional M&A advisory to strategic alternatives analysis, fairness opinions, and capital raising. Retainer arrangements are market-standard ($10K-$25K/month range), applied toward success fees. Fee structures typically follow modified Lehman formulas or negotiated percentages based on transaction size and complexity.
The firm requires minimum engagement sizes in the $10 million TEV range. They emphasize a 6-12 month process timeline, providing quality-of-earnings support, management presentation coaching, data room preparation, and ongoing strategic guidance through close.
Buyer Network & Strategic Positioning
Through five decades of transaction activity, Scott-Macon has built extensive relationships with private equity sponsors, strategic acquirers, and financial buyers. Their network spans regional PE firms (Audax, Genstar, Riverside), large PE platforms (Providence Equity, KKR), and strategic buyers across industrials, healthcare services, consumer goods, and specialized sectors. The firm's international presence, with offices and relationships in London and European markets, enables cross-border transactions and access to non-US buyers.
Their competitive positioning rests on three pillars: senior-level execution (Managing Directors on every engagement), operating expertise (several MDs are former COOs/CFOs), and independence (privately held, free from conflicts inherent in large platform banks).
Firm Structure & Leadership
Scott-Macon is independently held by SMG Associates, LLC, with no affiliation to larger financial services platforms. This structure enables truly unbiased advisory free from cross-selling conflicts. Leadership includes Jeff Tepper (Senior Managing Director, President & CEO), Nathan D. Cortright (Managing Director, Healthcare Group Head), Scott Silverman (Managing Director, Consumer & Retail), Bob Snape (Co-Founder & Senior Managing Director), and Allan Benton (Vice Chairman, Chemical Practice Head). The firm employs 51-200 professionals across specialized industry groups.
Regulatory Status
Scott-Macon Securities, Inc. is a FINRA-registered broker-dealer (CRD# 17406, SEC# 8-35184) with no disclosed disciplinary history. The firm maintains compliance with FINRA regulations and state securities laws across 14 states.
Geographic Coverage & Market Orientation
Primarily headquartered in New York (333 East 66th Street, Suite 2-O), with international reach through London relationships and network. Core North American markets include New York, major industrial centers, healthcare hubs, and Southeast regional markets.